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1. Introduction 
Paramecium has been shown to be sensitive to the 
bacterial antibiotics erythromycin and chloramphenicol 
and resistant mutants have been obtained. Evidence 
has been obtained that resistance is cytoplasmically 
inherited [ 1, 21 and is transferred by the mitochondria 
[3], implying that the mutation is in the mitochondrial 
DNA. Similar cytoplasmically inherited mutants have 
been obtained in yeast [4-91, where it has been shown 
that the mutation involves the mitochondrial DNA 
[lo, 1 I] The object of studying such mutants bio- 
chemically is to identify the mitochondrial components 
specified by mitochondrial DNA and this can be achieved 
by comparing the mitochondria from sensitive and re- 
sistant strains. 
Two possible mechanisms for resistance to erythro- 
mycin have been considered: 
i) an alteration in the mitochondrial membranes; 
ii) an alteration at the site of action of erythromycin 
i.e. the mitochondrial ribosomes. 
Indirect evidence for both these mechanisms has 
been obtained with the yeast mutants by examining 
the cross resistance to other antibiotics [ 121 and by 
the effect of antibiotics on amino acid incorporation 
into isolated mitochondria [6]. Direct evidence for 
alteration of the mitochondrial ribosome in one of 
these mutants has been obtained by studying the ef- 
fect of erythromycin on poly U catalysed phenylalanine 
incorporation, using isolated mitochondrial ribosomes 
from resistant and sensitive strains [ 131 . 
In the work to be described here, it is shown that 
the resistance of mutant 5 13Ey (EDIN) of Paramecium 
is due to an altered mitochondrial ribosome. This has 
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been shown directly by binding experiments using 
“C-labelled erythromycin. It has also been shown that 
the cytoplasmic ribosomes are unable to bind erythro- 
mycin and so can be distinguished from mitochondrial 
ribosomes. 
2. Methods and materials 
5 13ET (EDIN) was isolated from stock 5 13 of 
Paramecium aurelia as a spontaneous mutant, resistant 
to 250 pg/ml erythromycin. Paramecium was cultured 
on a grass infusion inoculated with A erobacter aerogenes 
[ 141 . 20 Litre cultures were concemtrated by continuous 
flow centrifugation and mitochondria prepared by 
homogenisation of pelleted cells in 0.2 M raffinose, 
0.01 M sodium phosphate pH 6.8 and 1 mg/ml bovine 
serum albumin, followed by differential centrifugation 
[ 1.51 . The mitochondrial pellet was washed twice in 
homogenisation buffer containing 1 mM EDTA. 
Mitochondrial ribosomes were prepared by lysing 
the twice washed mitochondrial pellet in 2% Triton 
X-100 in TMK (50 mM Tris HCl pH 7.5, 10 mM MgC12, 
10 mM KCl), centrifuging the lysate at 25,OOOg for 
30 min and layering the supernatant on 15-30s sucrose 
gradients in TMK [ 161 The gradients were centrifuged 
at 100,OOOg for 51 hr, the tubes were pierced, the 
effluent monitored at 260 nm and 1 ml fractions col- 
lected. 
Cytoplasmic ribosomes were prepared by differential 
centrifugation of homogenates; the ribosomal pellet was 
resuspended in TMK and layered on sucrose gradients. 
Erythromycin binding to mitochondrial ribosomes 
was undertaken using both isolated intact mitochondria 
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and lysed mitochondria. 
i) Isolated mitochondria (approx. 150 mg protein) 
were suspended in 10 ml M.I.M. (0.2 M sucrose, 10 
mM KCl, 10 mM MgC12, 1.3 mM EDTA, 0.02 M nico- 
tinamide, 0.01 M succinate, 16 mM K2HP04, 1 mg/ml 
bovine serum albumin titrated to pH 7.0 with KOH) 
and incubated for 10 min at 32” with 48 &ml of 
(methyl-14C] erythromycin (specific activity = 22.8 
yCi/mg). The incubation was terminated by cooling 
in ice and the mitochondria sedimented by centrifu- 
gation at 10,OOOg for 10 min through 25 ml of M.I.M. 
Mitochondrial ribosomes were then isolated as described 
above. 
ii) Lysed mitochondria were prepared as described 
in the preparation of mitochondrial ribosomes. The 
25,OOOg supernatant of the Triton X-100 lysate was 
incubated with 40 pg/ml [methyl-l4 C] erythromycin ’ 
for 10 min at 32” . The incubation was terminated by 
cooling in ice and the ribosomes were sedimented by 
centrifugation at 110,000 g for 14 hr. The pellet was 
resuspended in TMK and layered on 15-2770 sucrose 
gradients in TMK. 
Cytoplasmic ribosome binding of erythromycin was 
undertaken by resuspending the ribosomal pellet in 
1.5 ml of TMK and then treating as in (ii). 
Radioactivity was estimated by adding each gradient 
fraction to 10 ml toluene scintillation fluid and 2 ml 
NE 520 solubiliser (Nuclear Enterprises). 
I4 C-labelled erythromycin was a gift from Eli Lilly 
& Co. Ltd., Indianapolis. 
3. Results 
In order to determine whether the resistance to 
erythromycin was due to an alteration of the mito- 
chondria preventing the ribosomes interacting with 
erythromycin, isolated mitochondria were prepared 
from the mutant (5 13 Ef: (EDIN)) and sensitive strains 
and then incubated with radioactively labelled erythro- 
mycin. Ribosomes were then prepared from the mito- 
chondria by sucrose density gradient centrifugation. 
The fraction (1 ml) from such gradients were counted 
for radioactivity and the results of such a comparison 
are shown in fig. 1. 
The erythromycin binds to the mitochondrial rib- 
osomes from sensitive cells but not to those from re- 
sistant cells, showing that the mutation is associated 
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Fig.1. Sucrose gradient analysis of lysed sensitive (A) and rc- 
sistant (B) mitochondria after incubation of the intact mito- 
chondria with [ 14C] erythromycin. The main peak of absorp- 
tion at 260 nm constitutes the mitochondrial ribosomes. 
with an altered binding of erythromycin. This alteration 
could be due either to an alteration in the mitochondrial 
membrane in 5 13 Ey or to an alteration in the ribosomes 
themselves. 
In order to distinguish between these two possibilities, 
mitochondrial lysates containing the mitochondrial 
ribosomes, but no intact membrane, were incubated with 
[ I4 C] erythromycin. The mitochondrial ribosomes were 
then separated by sucrose density gradients and the 
fractions from the gradients counted for radioactivity. 
The results are shown in fig. 2; erythromycin again 
binds to the ribosomes of the sensitive strain but not 
to those of strain 5 13 Ey. As there is no mitochondrial 
membrane, this experiment demonstrates that the rib- 
osomes of 5 13 Ey are altered in their ability to bind 
erythromycin at this concentration. From figs. 1 and 2 
it can be seen that erythromycin binds to both the 80 S 
and 55 S peaks, prepared from sensitive cells. Preliminary 
results, involving lowering the magnesium ion concen- 
tration or treatment with EDTA. indicate that the 80 S 
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Fig.2. Sucrose gradient analysis of lysates from sensitive (A) 
and resistant (B) mitochondria after incubation of the lysate 
with [ 14C] erythromycin; showing the binding of erythromycin 
to mitochondrial ribosomes. 
peak represents the mitochondrial monosomes and that 
the 55 S peak contains both sub-units. These findings 
are in agreement with results obtained with the proto- 
zoan Tetrahymena [ 17, 181, where it has been shown 
that the mitochondrial ribosomes sediment at 80 S 
and dissociate into subunits both of which sediment 
at 55 S. 
The preparation of mitochondrial ribosomes des- 
cribed here could be contaminated with bacterial 
ribosomes from the culture or cytoplasmic ribosomes 
from endoplasmic reticulum. The possibility of contami- 
nation by bacterial ribosomes can be eliminated for the 
following reasons: 
i) The bacteria used for culturing are the same in 
resistant and sensitive strains of Paramecium and are 
sensitive to erythromycin. 
ii) 2% Triton X-100 does not lyse bacteria and so 
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bacterial ribosomes would not be present in the 
25,000 g supernatant of the mitochondrial lysate. 
iii) The mitochondrial ribosomes sediment at ap- 
prox. 80 S in sucrose gradients (unpublished observa- 
tions). 
In order to confirm that the difference in erythro- 
mycin binding was not due to differences in the cyto- 
plasmic ribosomes, a [ I4 C] erythromycin labelling 
experiment was undertaken using cytoplasmic ribosomes 
at the same concentration as the mitochondrial ribosomes 
in fig. 2. The results are shown in fig. 3 and although 
some counts are present throughout the gradient, no 
peak of radioactivity is associated with the ribosomes. 
Similar results were obtained when the ribosome con- 
centration was increased 6-fold. This shows that cyto- 
plasmic ribosomes do not bind [‘“Cl erythromycin 
and that the ribosome peaks observed in figs. 1 and 2 
are mitochondrial in origin. 
4. Discussion 
These experiments clearly show that the cytoplas- 
mically inherited mutation in 5 13 Ef: is associated 
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Fig.3. Sucrose gradient analysis of cytoplasmic ribosomes 
from sensitive cells, after incubation of the ribosomes with 
[ 14C] erythromycin. 
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